Aklief

Drug overview for AKLIEF (trifarotene):

Generic name: trifarotene (trye-FAR-oh-teen)
Drug class: Acne Products
Therapeutic class: Dermatological

Trifarotene, a retinoic acid receptor (RAR) agonist, is a retinoid skin agent.

No enhanced Uses information available for this drug.

DRUG IMAGES

AKLIEF 0.005% CREAM

The following indications for AKLIEF (trifarotene) have been approved by the FDA:

Indications:
Acne vulgaris

Professional Synonyms:
Acne simplex
Common acne
Simple acne

Dosing information for AKLIEF
DRUG LABEL	DOSING TYPE	DOSING INSTRUCTIONS
AKLIEF 0.005% CREAM	Maintenance	Adults apply to the affected area(s) by topical route once daily in the evening

Severe List
Eczema
Sunburn

The following adverse reaction information is available for AKLIEF (trifarotene):

Overview
Severe
Less Severe

Adverse reaction overview.

The most common adverse reactions (occurring in >=1% of patients receiving trifarotene cream) were application site irritation, application site pruritus, and sunburn.

There are 0 severe adverse reactions.

There are 12 less severe adverse reactions.

More Frequent	Less Frequent
Dry skin Erythema Pruritus of skin Skin irritation Skin scaling Stinging of skin Sunburn	None.

Rare/Very Rare
Acute pain at drug application site Allergic dermatitis Dyschromia Skin rash Skin swelling

The following precautions are available for AKLIEF (trifarotene):

Pediatric
Pregnant
Lactation
Geriatric

No enhanced Pediatric Use information available for this drug.

Contraindicated

None

Severe Precaution

None

Management or Monitoring Precaution

None

No enhanced Pregnancy information available for this drug.

No enhanced Lactation information available for this drug.

The manufacturer makes no specific dosage recommendations for geriatric patients.